realistic expectations, page-2

"Given the initial data presented last year as well as recent talk of tumours shrinking to such a degree that they are un-biopsiable (even after 9 months??), additional interim data could well be positive."

My comment to this quote from ousia's post is that this is of major significance and as such little emphasis was given to it in the lead up to the ipo. Should not presentations attempting to garner support pull out all stops in order to get over the line?